8,649,329 Shares in Phreesia, Inc. $PHR Purchased by Pale Fire Capital SE

Pale Fire Capital SE purchased a new stake in shares of Phreesia, Inc. (NYSE:PHR) in the first quarter, HoldingsChannel.com reports. The institutional investor purchased 8,649,329 shares of the company’s stock, valued at approximately $72,481,000. Phreesia comprises 6.2% of Pale Fire Capital SE’s portfolio, making the stock its 5th largest holding. Pale Fire Capital SE owned 0.14% of Phreesia as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of PHR. Royal Bank of Canada increased its stake in shares of Phreesia by 208.8% during the first quarter. Royal Bank of Canada now owns 24,119 shares of the company’s stock valued at $617,000 after purchasing an additional 16,309 shares in the last quarter. AQR Capital Management LLC lifted its holdings in shares of Phreesia by 471.2% during the first quarter. AQR Capital Management LLC now owns 160,032 shares of the company’s stock valued at $4,090,000 after purchasing an additional 132,015 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Phreesia by 3.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 62,557 shares of the company’s stock worth $1,599,000 after purchasing an additional 2,158 shares in the last quarter. NewEdge Advisors LLC boosted its position in shares of Phreesia by 262.7% in the 1st quarter. NewEdge Advisors LLC now owns 15,437 shares of the company’s stock worth $395,000 after purchasing an additional 11,181 shares in the last quarter. Finally, Goldman Sachs Group Inc. grew its stake in shares of Phreesia by 0.4% in the 1st quarter. Goldman Sachs Group Inc. now owns 600,012 shares of the company’s stock worth $15,336,000 after buying an additional 2,402 shares during the last quarter. Institutional investors own 92.10% of the company’s stock.

Phreesia Price Performance

Shares of NYSE PHR opened at $10.22 on Friday. Phreesia, Inc. has a twelve month low of $7.77 and a twelve month high of $32.76. The firm has a market cap of $631.53 million, a P/E ratio of 68.11 and a beta of 0.87. The company has a 50 day moving average of $9.86 and a 200 day moving average of $11.14. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.41.

Phreesia (NYSE:PHR) last released its quarterly earnings data on Wednesday, May 27th. The company reported $0.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.02 by $0.03. Phreesia had a return on equity of 5.13% and a net margin of 1.85%.The business had revenue of $130.94 million for the quarter, compared to analysts’ expectations of $130.08 million. During the same period in the prior year, the firm posted ($0.07) EPS. The firm’s quarterly revenue was up 12.9% on a year-over-year basis. As a group, research analysts expect that Phreesia, Inc. will post 0.39 EPS for the current fiscal year.

Wall Street Analyst Weigh In

PHR has been the subject of a number of analyst reports. BMO Capital Markets reduced their price objective on Phreesia from $32.00 to $14.00 and set an “outperform” rating for the company in a research report on Tuesday, March 31st. Canaccord Genuity Group dropped their target price on Phreesia from $22.00 to $16.00 and set a “buy” rating on the stock in a report on Thursday, May 28th. Barclays reissued an “equal weight” rating and issued a $10.00 target price (down from $24.00) on shares of Phreesia in a research note on Thursday, May 14th. Citigroup restated a “market perform” rating on shares of Phreesia in a report on Friday, May 29th. Finally, DA Davidson reaffirmed a “buy” rating and issued a $14.00 price target on shares of Phreesia in a research report on Thursday, May 28th. Nine analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $16.65.

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.